ROS and GSH-responsive S-nitrosoglutathione functionalized polymeric nanoparticles to overcome multidrug resistance in cancer
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Acta Biomaterialia
- Vol. 103, 259-271
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (21602024)
- Fundamental Research Funds for the Central Universities (2018CDYXYX0027)
- Fundamental Research Funds for the Central Universities (0247001104416)
This publication has 41 references indexed in Scilit:
- Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancerNitric Oxide, 2013
- Poly(PS-b-DMA) micelles for reactive oxygen species triggered drug releaseJournal of Controlled Release, 2012
- Multi-arm polymeric nanocarrier as a nitric oxide delivery platform for chemotherapy of head and neck squamous cell carcinomaBiomaterials, 2012
- Nitric oxide release: Part III. Measurement and reportingChemical Society Reviews, 2012
- Treatment of doxorubicin-resistant MCF7/Dx cells with nitric oxide causes histone glutathionylation and reversal of drug resistanceBiochemical Journal, 2011
- Cdk2 nitrosylation and loss of mitochondrial potential mediate NO-dependent biphasic effect on HL-60 cell cycleFree Radical Biology and Medicine, 2010
- Nitric Oxide-Releasing Silica Nanoparticle Inhibition of Ovarian Cancer Cell GrowthMolecular Pharmaceutics, 2010
- CONTROLLED DELIVERY OF NITRIC OXIDE INHIBITS LEUKOCYTE MIGRATION AND PREVENTS VASOSPASM IN HAPTOGLOBIN 2-2 MICE AFTER SUBARACHNOID HEMORRHAGENeurosurgery, 2009
- Reversible RS–NO bond cleavage and formation at copper(i) thiolatesChemical Communications, 2009
- Direct evidence of singlet molecular oxygen generation from peroxynitrate, a decomposition product of peroxynitriteDalton Transactions, 2009